DK0458537T3 - Anvendelse af en terapeutisk forbindelse til behandling af bronkitis - Google Patents

Anvendelse af en terapeutisk forbindelse til behandling af bronkitis

Info

Publication number
DK0458537T3
DK0458537T3 DK91304449T DK91304449T DK0458537T3 DK 0458537 T3 DK0458537 T3 DK 0458537T3 DK 91304449 T DK91304449 T DK 91304449T DK 91304449 T DK91304449 T DK 91304449T DK 0458537 T3 DK0458537 T3 DK 0458537T3
Authority
DK
Denmark
Prior art keywords
treatment
bronchitis
therapeutic compound
ofbronchitis
medicament
Prior art date
Application number
DK91304449T
Other languages
English (en)
Inventor
Mitchell Glass
Joseph Campbell Williams
Original Assignee
Zeneca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zeneca Ltd filed Critical Zeneca Ltd
Application granted granted Critical
Publication of DK0458537T3 publication Critical patent/DK0458537T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
DK91304449T 1990-05-24 1991-05-17 Anvendelse af en terapeutisk forbindelse til behandling af bronkitis DK0458537T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US52865790A 1990-05-24 1990-05-24

Publications (1)

Publication Number Publication Date
DK0458537T3 true DK0458537T3 (da) 1999-10-18

Family

ID=24106599

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91304449T DK0458537T3 (da) 1990-05-24 1991-05-17 Anvendelse af en terapeutisk forbindelse til behandling af bronkitis

Country Status (12)

Country Link
EP (1) EP0458537B1 (da)
JP (1) JPH04235133A (da)
AT (1) ATE178336T1 (da)
AU (1) AU648078B2 (da)
CA (1) CA2043107A1 (da)
DE (1) DE69131058T2 (da)
DK (1) DK0458537T3 (da)
ES (1) ES2129401T3 (da)
GR (1) GR3029726T3 (da)
IE (1) IE911698A1 (da)
IL (1) IL98200A0 (da)
ZA (1) ZA913920B (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5162348A (en) * 1990-05-24 1992-11-10 Imperial Chemical Industries Plc Treatment of cystic fibrosis
ATE164074T1 (de) * 1990-05-24 1998-04-15 Zeneca Ltd Therapeutisches mittel zur vorbeugung und behandlung des atemnotsyndroms bei erwachsenen
GB9113164D0 (en) * 1991-06-18 1991-08-07 Ici Plc Pharmaceutical agent
DE10138294C5 (de) * 2001-08-10 2006-09-28 Db Netz Ag Verfahren und Vorrichtung zum Auswechseln eines Fahrdrahtes an einer Oberleitung

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1986000077A1 (en) * 1984-06-14 1986-01-03 Cortech, Inc. Human leukocyte elastase inhibitors prepared from pyogenic bacteria and methods for their purification
GB8600263D0 (en) * 1985-01-22 1986-02-12 Ici America Inc Peptide derivatives
EP0276101A3 (en) * 1987-01-19 1989-11-23 Ici Americas Inc. Substituted peptide derivatives
GB8809316D0 (en) * 1987-05-11 1988-05-25 Ici America Inc Heterocyclic ketones
GB8808701D0 (en) * 1988-04-13 1988-05-18 Erba Carlo Spa Beta-lactam derivatives
DE68925923T2 (de) * 1988-06-10 1996-11-14 Merck & Co Inc Antigene der einzigen Spaltungsstelle von Fibrinogen durch Elastase
EP0369391A3 (en) * 1988-11-15 1991-09-25 Boehringer Ingelheim Pharmaceuticals Inc. N-substituted amides
NO177716C (no) * 1989-06-09 1995-11-08 Zeneca Ltd Fremgangsmåte for fremstilling av terapeutisk aktive polypeptider, DNA-sekvens, ekspresjonsvektor og antistoff
US5162348A (en) * 1990-05-24 1992-11-10 Imperial Chemical Industries Plc Treatment of cystic fibrosis

Also Published As

Publication number Publication date
ES2129401T3 (es) 1999-06-16
DE69131058D1 (de) 1999-05-06
EP0458537B1 (en) 1999-03-31
ZA913920B (en) 1992-02-26
GR3029726T3 (en) 1999-06-30
JPH04235133A (ja) 1992-08-24
AU7719491A (en) 1991-11-28
IL98200A0 (en) 1992-06-21
AU648078B2 (en) 1994-04-14
EP0458537A3 (en) 1992-07-08
IE911698A1 (en) 1991-12-04
CA2043107A1 (en) 1991-11-25
EP0458537A2 (en) 1991-11-27
ATE178336T1 (de) 1999-04-15
DE69131058T2 (de) 1999-09-09

Similar Documents

Publication Publication Date Title
ATE169219T1 (de) Behandlung von katarakt mit 15-keto- prostaglandinderivaten
DK0435443T3 (da) Anvendelse af en 15-ketoprostaglandinforbindelse til forbedring af den encephaliske funktion
DK168189D0 (da) Topisk praeparat til behandling af otopati
ATE133663T1 (de) Antiglancoma-zusammensetzungen enthaltend 3- arylcarbonyl-1-aminoalkyl-1h-indol
ATE174221T1 (de) Behandlung von pankreaskrankheit mit 15-keto- prostaglandin e-derivaten
DE69104448T2 (de) Faserbehandlungsmittelzusammensetzung.
ATE137116T1 (de) Behandlung von entzündlichen erkrankungen mit 15- ketoprostaglandinen
DK0458589T3 (da) Behandling af okulær hypertension med en okulær synergistisk kombination
DK161320C (da) Analogifremgangsmaade til fremstilling af 2,3-diaryl-5-halogen-thiophener
DK0424156T3 (da) Behandling af hepatobiliær sygdom med 15-ketoprostaglandinforbindelser
DK0430551T3 (da) Behandling af hjertedysfunktion med 15-keto-prostaglandinforbindelser
DK0458590T3 (da) Behandling af okulær hypertension med en synergistisk konbination
FI891473A (fi) Menetelmä terapeuttisesti käyttökelpoisten 4-aryyli-4-piperidiinikarbinolien valmistamiseksi
DK0458537T3 (da) Anvendelse af en terapeutisk forbindelse til behandling af bronkitis
DE69023459T2 (de) Behandlung von pulmonarer Disfunktion mit 15-Keto-prostaglandin-Derivaten.
DK0469782T3 (da) Behandling af katarakt med prostacyclinforbindelser
DK0730861T3 (da) Anvendelse af 6,7-substituerede 2-aminotetraliner til fremstilling af farmaceutiske præparater, der er nyttige til behandli
ATE72115T1 (de) Anwendung von 1,6-dimethyl-4-oxo-1,6,7,8,9a-
IT1237087B (it) N,n'-di-(trimetossibenzoil) piperazine 2-metossicarbonil sostituite, procedimento per preparare le stesse e composti terapeutici che le contengono.